Erica A. Power

Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs

Victor M. Lu, D.J. Daniels, Julian S Rechberger, 2019, Child's Nervous System.

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time

E. Hinchcliffe, W. Elmquist, D.J. Daniels, 2023, Neuro-oncology advances.

Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies

Cody L. Nesvick, Julian S. Rechberger, Leo F. Nonnenbroich, 2023, Expert opinion on therapeutic targets.

Drug Delivery Across the Blood-Brain Barrier for the Treatment of Pediatric Brain Tumors - An Update.

S. Khatua, D.J. Daniels, Julian S Rechberger, 2022, Advanced drug delivery reviews.

Liquid biopsy for diffuse intrinsic pontine glioma: an update.

Victor M. Lu, D.J. Daniels, Erica A Power, 2019, Journal of neurosurgery. Pediatrics.

Evolution of neurosurgical advances and nuances in medulloblastoma therapy.

Julian S. Rechberger, Michael DeCuypere, Erica A. Power, 2023, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery.

CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?

Elena Millesi, Julian S. Rechberger, Erica A. Power, 2024, Immunotherapy.

Murine Central Nervous System and Bone Marrow Distribution of the Aurora A Kinase Inhibitor Alisertib: Pharmacokinetics and Exposure at the Sites of Efficacy and Toxicity

David J. Daniels, W. Elmquist, Erica A Power, 2022, The Journal of Pharmacology and Experimental Therapeutics.

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma

T. Peterson, P. Decker, E. Hinchcliffe, 2022, Neuro-oncology.

Unlocking the translational potential of circulating nucleosomes for liquid biopsy in diffuse intrinsic pontine glioma.

Victor M. Lu, D.J. Daniels, Erica A Power, 2019, Biomarkers in medicine.